NCT05837104
Efficacy and Safety of Magnesium Vitamin B6 in First Episode Bipolar Disorder
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 10 versions: 9 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 28 words Show 6 more changesShow less
- Trial completed
- Final enrollment: 22 participants (planned 40)
- Primary and study completion dates changed from estimate of Oct 2026 to Oct 30, 2026
- Secondary endpoints: details revised at 4 of 10 entries
- Study description revised
- Site details revised
- Notable Primary and study completion dates: Dec 2025 to Oct 2026v8
- Notable Eligibility criteria shortened, about 4 wordsv7
- Notable Eligibility criteria shortened, about 20 wordsv6
- Notable Trial status: Not Yet Recruiting to Recruiting
- Study sites: 0 to 1
- Primary and study completion dates: Oct 2025 to Dec 2025
- Start date changed from estimate of Nov 2023 to Dec 13, 2023
Show 3 earlier versionsHide 3 earlier versions
- Notable Primary and study completion dates pushed to Oct 2025
- Start date: Aug 2023 to Nov 2023
- Secondary endpoints: 7 to 10
- Notable Start date: May 2023 to Aug 2023
- Primary completion date: May 2024 to Aug 2024
- Study completion date: May 2025 to Aug 2025
- Minor Secondary endpoints revised (7)
- Study description expanded, about 1 word
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Change in depressive symptoms
Timeframe: 4 weeks
Secondary (10)
Change in anxiety symptoms
Change in stress symptoms
Change in Clinical Global Impression (CGI) Scale
Change in cognitive measure
Changes in brain ATP
Show 5 moreShow less
Changes in brain PCr
Changes in brain pH
Changes in brain inorganic phosphate concentration
Change in brain Mg2+ concentration
Change in adverse events
Arms and interventions
Magnesium vitamin B6Experimental
Magnesium vitamin B6 (MagnéVie B6®) composed of Magnesium citrate (100mg) and Pyridoxine hydrochloride (10mg) in tablet form, taken three times daily for four weeks.
PlaceboPlacebo comparator
Placebo tablet will be taken three times daily for four weeks.
Drugs: Magnesium vitamin B6, Placebo
Sites
1 site in 1 country
- McLean HospitalBelmont, Massachusetts, United States